Post My Press Release

Free Press Release Distribution

Category: Biotechnology (Page 1 of 102)

Transcriptomics Technologies Market Major Advancements, Industry Analysis And Future Growth Till 2022 : Grand View Research Inc.

San Francisco, 15 May 2019: The Report Transcriptomics Technologies Market Analysis By Technology (Microarray, PCR, Gene Regulation, Next Generation Sequencing), By Application (Clinical Diagnostics, Drug Discovery & Research, Bioinformatics, Comparative Transcriptomics) And Segment Forecasts To 2022

The global transcriptomics technologies market is expected to reach USD 6.9 billion by 2022, according to a new report by Grand View Research Inc. The increasing demand for genetic identification and growing investment in R&D innovation along with the technological advancements across the product portfolio are the vital driving forces of this market. The increasing R&D investments are expected to highly influence biotechnological research and develop the commercialization over the forecast period. The rising investment is further anticipated to ensure positive growth and enhance business opportunities for pharmaceutical and biotechnological companies. 

Furthermore, the rising demand for efficient diagnostic methods drives the need for personalized medicines. Transcriptomics tools and the offered services identify potential drug targets, which are effective methods for diagnostic methodologies. The shifting preference of pharmaceutical companies towards therapeutics results in rising demand for the disease specific biomarker identification. This change ensures a potential opportunity in the commercialization of transcriptome research results. The escalating demand for efficient diagnostics and treatment measures in the areas of oncology, HIV, Alzheimer’s disease, etc., also contributes significantly towards transcriptomics technologies market growth. 

Access Research Report of Transcriptomics Technologies Market @ www.grandviewresearch.com/industry-analysis/transcriptomics-technologies-market

Further key findings from the report suggest:

  • Polymerase Chain Reaction (PCR) based transcriptomics technologies market is expected to account for over 40% market share by 2022 owing to its ability to enable amplification even from very small amounts of genetic material samples
  • Next Generation Sequencing based transcriptomics technologies market is expected to grow at a lucrative CAGR of over 17.0% over the forecast period owing to increased outsourcing of sequencing technologies, upgrading of technology enabling the analysis of cellular transcriptome from various dimensions, and wide application areas of NGS
  • North America dominates the transcriptomics technologies market in terms of revenue owing to the increasing R&D activities by the biotechnology and pharmaceutical companies
  • North America and Asia Pacific are expected to witness fastest growth of over 15.0% during the forecast period. The growth is due to the presence of untapped opportunities, rising expenditure level, and the introduction of favorable government initiatives.
  • Key players of transcriptomics technologies market include Agilent Technologies, Affymetrix, Thermo Fisher Scientific, Illumina, Life Technologies, and F. Hoffmann-La Roche
  • Market participants are constantly engaged in strategic collaborations such as mergers and acquisitions along with technological advancements in an attempt to improve presence and ensure sustainability
  • For instance, in May 2015, Agilent Technologies announced the acquisition of Cartagenia that provides services and software for clinical genetic analysis. Their products are supplied to pathology laboratories and clinical research institutes. The acquisition is expected to provide higher integration and support customer satisfaction. 

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the global transcriptomics technologies market on the basis of technology, applications, and region:

Transcriptomics Technology Outlook (Revenue, USD Million, 2012 – 2022)

  • Microarray
  • PCR
  • Gene Regulation Technologies
  • Next Generation Sequencing 

Transcriptomics Technology Application (Revenue, USD Million, 2012 – 2022)

  • Clinical Diagnostics
  • Drug Discovery and Research
  • Bioinformatics
  • Comparative Transcriptomics

Transcriptomics Technologies Regional Outlook (Revenue, USD Million, 2012 – 2022)

  • North America
  • Europe
  • Asia Pacific
  • RoW

Access Press Release of Transcriptomics Technologies Market @ www.grandviewresearch.com/press-release/global-transcriptomics-technologies-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Transplantation Market Industry Trends, Revenue Growth Forecast 2025 : Grand View Research Inc.

San Francisco, 30 May 2019: The Report Transplantation Market By Product (Tissue Products, Immunosuppressive Drugs, Preservation Solutions), By Application (Organ, Tissue Transplantation), By End-use, And Segment Forecasts, 2018 – 2025

The global transplantation market is expected to reach USD 51.0 billion by the year 2025, growing at a CAGR of 9.1%, according to a new report by Grand View Research, Inc. Growing incidence of organ failure has resulted in massive growth in the transplantation market. Rising demand for transplant products such as tissue products, immunosuppressants, and organ preservation solutions is a major factor anticipated to boost growth of the market during forecast period. Thus, many biotechnology and medical device companies have begun to concentrate on the development of advanced transplant products for management of organ failure.

Technological advancement in organ transplantation methods is another major factor supporting the market growth. The development of novel & improved transplant products such as tissue products  and surgical instruments has majorly contributed to the expansion of the sector. In addition, introduction of advanced tissue products such as DeNovo NT Graft, Chondrofix Osteochondral Allograft, and DuraMatrix Collagen Dura Substitute Membrane provides higher benefits during treatment.  In addition, computerized support systems with advanced systems and software allow easy & effective maintenance of tissues. Thus, availability of such advanced techniques supports increase in the number of organ transplant procedures.

Access Research Report of Transplantation Market @ www.grandviewresearch.com/industry-analysis/transplantation-market

Further key findings from the report suggest:

  • Tissue products segment was the largest revenue-generating amongst others due to escalating number of tissue and organ transplant procedures
  • Tissue products segment is also expected to grow at highest CAGR owing to advancement in transplantation products
  • Tissue transplant segment held the largest revenue share in the market, because of rising number of skin, bones, heart valves, cornea, tendons, nerves, and veins procedures worldwide
  • The transplant centers segment is projected to grow at the highest CAGR during the forecast period owing to rising popularity of these centers for transplant procedures
  • The hospitals segment dominated the market in terms of revenue in 2016 owing to a large number of transplant procedures performed in hospitals
  • North America was the leading regional sector in 2016 and is projected to maintain its dominance during the forecast period owing to well-developed healthcare infrastructure
  • Existence of large number of research laboratories, biotechnology, and medical device companies in the North America region is the major factor contributing to its large share
  • Some of the major players include AbbVie, Inc.; Arthrex, Inc.; Zimmer Biomet; Medtronic; Novartis AG; Stryker; 21st Century Medicine; BioLifeSolutions, Inc; Teva Pharmaceuticals; and Veloxis Pharmaceuticals.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the global transplantation market on the basis of product, application, end-use, and region:

Product Outlook (Revenue, USD Billion; 2014 – 2025)

  • Tissue products
  • Immunosuppressive drugs
  • Preservation solutions

Application Outlook (Revenue, USD Billion; 2014 – 2025)

  • Organ transplantation
  • Tissue transplantation

End-Use Outlook (Revenue, USD Billion; 2014 – 2025)

  • Hospitals
  • Transplant centers
  • Others

Regional Outlook (Revenue, USD Billion; 2014 – 2025)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Access Press Release of Transplantation Market @ www.grandviewresearch.com/press-release/global-transplantation-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Practice Management System Market – Global Trends, Industry Size, Growth, Opportunities

According to the new market research report “Practice Management System Market by Components (Software, Services), Delivery Mode (On-Premises/Desktop-Only, Cloud-Based, Web-Based), Products (Integrated, Standalone), & by End-Users (Pharmacist, Physician, Diagnostic Labs) – Global Trends & Forecast to 2018”, published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).

The global practice management system market is poised to grow at a high single-digit CAGR from 2013-2018 to reach $247.1 million by 2018.
The future growth prospect for the global practice management system market is optimistic and is estimated to grow at a decent CAGR of 8.6%to reach the market size of $247.1 million by 2018. The integrated PM system is the largest segment of this market. However, the cloud-based segment is the fastest growing segment with 12.1% CAGR from 2013-2018.

Burden of escalating care costs need for integrated care system, and rising federal incentives are expected to positively influence the market growth, while lack of data confidentiality and exorbitant amount of time consumption for integration will hamper the growth momentum. The major challenge prevailing in this industry includes shortage of on-site IT support services. The emerging markets of Middle East, Australia, New Zealand, China, and India, cloud-based practice management system, and growing demand for patient-centric care approach present several growth opportunities for market participants operating in this arena.

Don’t miss out on business opportunities in Practice Management System Market. 
Read Our Research Insight – https://www.marketsandmarkets.com/ResearchInsight/medical-practice-management-software.asp

The practice management system market is segmented based on products (integrated and standalone), delivery mode (on-premises, web-based, and cloud-based), components (services and software), end users (physicians, pharmacists, diagnostic labs and others), and geography.
Based on products, the PM system market is divided into integrated and standalone solutions. The integrated PM segment is expected to grow at a decent growth rate owing to government mandates for integration of electronic health records (EHR) with PM system and meaningful use incentive program.

On the basis of delivery mode, the practice management system market is further classified as on-premises, web-based, and cloud-based. The cloud-hosted solutions accounted for the fastest growing segment due to remote accessibility of data and reduced operational costs. By end-user the industry is segmented into physicians, pharmacists, and diagnostic labs. The physician segment accounted for the largest as well as the fastest growing segment of the market in 2013.

The key industry participants in the market are Allscripts Healthcare Solutions, Inc. (U.S.), athenahealth, Inc. (U.S.), Cerner Corporation (U.S.), Epic (U.S.), GE Healthcare (U.K.), Greenway Medical (U.S.), MEDITECH (U.S.), McKesson Corporation (U.S.), and NextGen Healthcare Information System LLC (U.S).

Know more about practice management system market – https://www.marketsandmarkets.com/PressReleases/medical-practice-management-software.asp

Medical Holography Market

Global Medical Holography Market – Industry Trends and Forecast to 2021

According to a new market research report “Medical Holography Market by Product (Holographic Display, Microscope, Print, Software), Application (Medical Imaging, Medical Education, Biomedical Research), End User (Medical Schools, Pharmaceutical Companies, Hospitals) – Global Forecast to 2021″ published by MarketsandMarkets, The Global Medical Holography Market Is Projected to Reach USD 953.9 Million by 2021, at a CAGR of 33.7% from 2016 to 2021.

The growth in this market can be mainly attributed to the growing clinical applications of holography in the healthcare sector, rising adoption of holography products in biomedical research and medical education, and emergence of holography as a promising technology in representing complex 3D structures. In this report, the global Medical Holography Market is segmented on the basis of product type, application, end user, and region. Based on product type, the market is segmented into holographic displays, holography microscopes, holographic prints, holography software and holoscopes. On the basis of application, the Medical Holography Market is segmented into three segments namely medical imaging, medical education, and biomedical research. While on the basis of end user, the Medical Holography Market is segmented into research laboratories, academic medical centers, pharmaceutical and biotechnology companies, and hospitals and clinics.

In 2015, the holographic displays product segment accounted for the largest share of the Medical Holography Market. This market is primarily driven by the increasing adoption of holographic displays in diagnostic imaging and for medical teaching and training as these displays provide high-quality real-time 3D images which attracts the user effectively.

Download an Illustrative overview of the report – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=183930222

In 2015, North America represented the largest regional market, followed by Europe, Asia-Pacific, and the RoW. North America represents the fastest-growing region for the Medical Holography Market, primarily due to increasing research initiatives in holography technology, adoption of holographic products by research laboratories and academic centers, and increasing healthcare expenditure in the U.S.

The medical holography market in North America is expected to grow at the highest CAGR during the forecast period. Factors such as increasing demand for noninvasive and radiation-free imaging techniques coupled with the growing geriatric population and increasing number of imaging procedures across the region are driving the growth of regional market.

Key players in the market include EchoPixel, Inc. (US), RealView Imaging Ltd. (Israel), Mach7 Technologies Pte. Ltd. (Australia), Ovizio Imaging Systems (Belgium), Holoxica Ltd. (UK), zSpace, Inc. (US), Lyncée Tec (Switzerland), Eon Reality (US), Zebra Imaging (US), Nanolive SA (Switzerland), and Holografika Kft. (Hungary). Some of the key strategies adopted by the market players include new product launches; investments; mergers and acquisitions; and agreements, collaborations, and partnerships. 

Know more about Medical Holography Market – https://www.marketsandmarkets.com/PressReleases/medical-holography.asp

Bone Morphogenetic Protein Market Expected To Propel Industry Growth By Size ,Share And Forecast To 2024 : Grand View Research Inc.

San Francisco, 25 June 2019: The Report Bone Morphogenetic Protein Market Analysis By Type (rhBMP-2, rhBMP-7), By Application (Spinal Fusion, Trauma, Reconstruction, Oral Maxillofacial Surgery), By Region (North America, Europe, APAC, LATAM, MEA), And Segment Forecasts, 2018 – 2024

The global bone morphogenetic protein (BMP) market size is expected to reach over USD 644.6 million by 2024, based on a new report by Grand View Research, Inc. Increasing incidence of spinal fusion, trauma, and small bone surgeries coupled with demand for faster bone recovery are the key drivers affirming growth of BMP market.

Low back pain and spinal disc dislocation are some of the most common occupational hazards. Over 75% of such disorders require spinal surgery after noninvasive treatment options are unable to provide any relief. Minimally invasive surgery, shorter hospital stays, and fast recovery are common demands observed among patients. BMP has gained high acceptance among orthopedic surgeons in recent years owing to its ability to cater above mentioned benefits

Sport-related injuries, growing geriatric population, and increasing awareness about osteoinduction products as an alternative to bone grafting are other drivers accentuating market growth. BMP has reported outstanding results over bone graft, such as lack of donor morbidity, extensive surgical procedure, higher recovery time, pain & numbness, and high cost.

Access Research Report of Bone Morphogenetic Protein Market @ www.grandviewresearch.com/industry-analysis/bone-morphogenetic-proteins-market

Further Key Findings From the Study Suggest:

  • rhBMP-2 and rhBMP-7 are the commercially available recombinant BMPs. rhBMP-2 is widely known for its high osteoinductive property for faster formation of bone and cartilage in bone fusion procedures
  • rhBMP-2 held more than half of the market share in 2015. Key attributes contributing toward its growth are high acceptance, wide range of applications, and easier availability in developing countries
  • rhBMP-7 on the other hand is expected to witness decline in market share over the forecast period owing to factors such as limited usage and discontinuation of OP-1from 2014 by Olympus
  • Spinal fusion held the largest share in 2015. Increasing cases of sport-related spinal injuries, wide range of product availability, easier usage, and long-term reliability are major factors for the aforementioned dominance.
  • North America held a significant share of over 65.0% in 2015. High number of orthopedic surgical procedures, and availability of favorable reimbursement policies are drivers that can be attributed to for largest share.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the bone morphogenetic protein market on the basis of type and applications:

Type Outlook (Market Revenue in USD Million, 2013 – 2024)

  • rhBMP-2
  • rhBMP-7

Application Outlook (Market Revenue in USD Million, 2013 – 2024)

  • Spinal fusion
  • Trauma
  • Reconstruction
  • Oral Maxillofacial

Regional Outlook (Market Revenue in USD Million, 2013 – 2024)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Access Press Release of Bone Morphogenetic Protein Market @ www.grandviewresearch.com/press-release/global-bone-morphogenetic-proteins-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Drug Discovery Informatics Market Growth Analysis, Share And Forecasts To 2025 : Grand View Research Inc.

San Francisco, 9 July 2019: The Report Drug Discovery Informatics Market Size, Share & Trends Analysis Report By Workflow (Discovery, Development), By Mode (In-house, Outsourced), By Services, By Region, Vendor Landscape, And Segment Forecasts, 2018 – 2025

The global drug discovery informatics market size is expected to reach USD 2.07 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 12.6% during the forecast period. Drug therapy is evolving in response to health care needs of the population. The most recent trend is to develop drugs for treatment of chronic diseases, especially those affecting the older population.

Cardiovascular Diseases (CVDs), stroke, and cancer are the most prevalent health issues and also the most common conditions causing death. Moreover, treatment expenses and costs pertaining to these diseases are very high, which triggers the demand for effective novel molecules. In the U.S. alone, revenue generated through CVD treatments was over USD 444 billion in 2010, and it has been estimated to claim more lives each year than the remaining causes of death combined.

Clinical decision support tools, which include online database for assistance in enhancement of clinical decisions, are timely updated and that significantly impacts market growth. Moreover, the World Health Organization’s Consultative Expert Working Group for Research and Development is also involved in evaluation and development of open source drug discovery platforms. Introduction of open drug discovery tool kit (ODDT), which serves as a tool for computer-aided drug discovery by implementing machine learning scoring functions (RF-Score and NN-Score), is anticipated to work in favor of the market.

Access Research Report of Drug Discovery Informatics Market @ www.grandviewresearch.com/industry-analysis/drug-discovery-informatics-market

Further key findings from the report suggest:

  • Lead generation and lead optimization are anticipated to witness hand-in-hand growth owing to usage of similar IT solutions
  • Presence of different co-operation models, such as joint ventures, strategic partnership, price competition, and project selection, for outsourcing drug informatics solutions in the industry is influencing the growth of the market positively
  • North America is projected to hold prominent position in the arena throughout the forecast period. Higher incidence rates of different infectious diseases and oncology diseases are expected to drive the demand for informatics solutions to aid drug discovery and development. Presence of molecular R&D laboratories and market players in the U.S. is supplementing the growth of the regional market
  • Asia Pacific is likely to post the highest CAGR during the same period, owing to cost saving advantage offered by the region
  • Some of the key players operating in the market Boehringer Ingelheim GmBh; ChemAxon; Jubilant Biosys; Certara; Selvita; Novo Informatics; Albany Molecular Research Inc.; Infosys; DiscoverX; Collaborative Drug Discovery Inc; GVK Biosciences; and Charles River Laboratories.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the global drug discovery informatics market on the basis of workflow, mode, service, and region:

Drug Discovery Informatics Workflow Outlook (Revenue, USD Million, 2014 – 2025)

  • Discovery Informatics
    • Identification & Validation Informatics Assay Development Informatics
    • Lead Generation Informatics
  • Development Informatics
    • Lead Optimization
    • FHD Preparation
    • Phase IA Informatics
    • Phase IB/2 Informatics

Drug Discovery Informatics Mode Outlook (Revenue, USD Million, 2014 – 2025)

  • In-house Informatics
  • Outsourced Informatics

Drug Discovery Informatics Service Outlook (Revenue, USD Million, 2014 – 2025)

  • Sequence Analysis Platforms
  • Molecular Modeling
  • Docking
  • Clinical Trial Data Management
  • Others

Drug Discovery Informatics Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Access Press Release of Drug Discovery Informatics Market @ www.grandviewresearch.com/press-release/global-drug-discovery-informatics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Stem Cell Therapy Market worth $161.8 Million in 2022

The Stem Cell Therapy Market market is expected to reach USD 161.8 million by 2022, growing at a CAGR of 11.0% during the forecast period. Factors such as the growing awareness related to the therapeutic potency of stem cells in disease management, development of advanced genome-based cell analysis techniques, increasing public-private investments for stem cell research, identification of new stem cell lines, and developments in infrastructure for stem cell banking and processing are propelling the growth of the global stem cell therapy market.

Download PDF Brochure: – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=48

Product Analysis

  • Product Matrix which gives a detailed comparison of the product portfolios of the top five companies

Geographical Analysis

  • Further breakdown of the North American stem cell therapy market into the US and Canada
  • Further breakdown of the European stem cell therapy market into the UK, Germany, France, and Rest of Europe

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

The global stem cell therapy market is expected to reach USD 145.8 million by 2021, growing at a CAGR of 11.0% during the forecast period. Factors such as the growing awareness related to the therapeutic potency of stem cells in disease management, ongoing development of advanced genome-based cell analysis techniques, increasing public-private investments for stem cell research and product development, identification of new stem cell lines, and developments in infrastructure for stem cell banking and processing are driving the growth of the global stem cell therapy market.

Read more (Stem Cell Therapy Market):-

https://www.marketsandmarkets.com/PressReleases/stem-cells-market.asp

The Major Players in this Market :

As of 2016, Osiris Therapeutics, Inc. (U.S.), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), Pharmicell Co., Ltd. (South Korea), Holostem Terapie Avanzate S.r.l. (Italy), JCR Pharmaceuticals Co., Ltd. (Japan), NuVasive, Inc. (U.S.), RTI Surgical, Inc. (U.S.), and AlloSource (U.S.) were some of the key players operating in the global stem cell therapy market.

Parkinson’s Disease Treatment Market Overview 2019-2022

The Parkinson’s disease treatment market was valued at USD 3.99 billion in 2016 and expected to grow at a CAGR of 6.1% from 2017 to 2022 to reach USD 5.69 billion in 2022.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=47265247

 The major driving factors for this market include ageing population and government funding for research, growing healthcare awareness.  The base year considered for the study is 2016, and the forecast has been provided for the period between 2018 and 2023.

Top Key Players

Key players operating in the Parkinson’s disease treatment market include Teva (Israel), Novartis AG (Switzerland), GSK (UK), AbbVie (US), Merck (US), Boehringer Ingelheim (Germany), Impax Laboratories (US), Lundbeck (Denmark), UCB (Belgium), Valeant Pharmaceuticals (Canada), Acadia (US), Sun Pharma (India), Wockhardt (India), Dr. Reddy’s (India), Intas (India), US WorldMeds (US), Zydus Cadila (India), Cipla (India), Strides (India), 1 A Pharma (India), and Upsher-Smith (US).

Major Develpoments: 

  • In 2016, ACADIA Pharmaceuticals, Inc. (U.S.) received FDA approval for its NUPLAZID drug
  • In 2016, Sun Pharmaceutical Industries Ltd. (India) entered distribution agreement with Mitsubishi Tanabe Pharma Corporation (Japan) to distribute 14 prescription brands that include Parkinson’s disease drug Parlodel in Japan

The Parkinson’s disease treatment market is segmented on the basis of drug class, distribution channel, patient care setting, and region. On the basis of drug class, the market is segmented into carbidopa/levodopa, dopamine receptor agonists, MAO-inhibitors, COMT-inhibitors, anticholinergics and other drugs. The carbidopa/levodopa segment is expected to account for the largest share of the market in 2017. The growth in this segment is primarily attributed to the potency of the drug.

By distribution channel, the market is segmented into hospital pharmacies, retailer pharmacies, and online pharmacies. In 2017, the hospital pharmacies segment accounted for the largest share of the market. Increasing number of patient visits to the hospital due to the availability of diagnostic laboratories and presence of skilled neurologists are driving the growth of hospital pharmacies segment.

On the basis of patient care setting, the Parkinson’s disease treatment market is segmented into hospitals and clinics. In 2017, hospitals are expected to account for the largest share of the market. Robust health infrastructure and presence of skilled neurologists are the driving factors for hospital segment.

Page 1 of 102

Powered by WordPress & Theme by Anders Norén